In breast cancer cells, treatment with paclitaxel induces the release of exosomes highly enriched in the protein Survivin, a member of the inhibitor of apoptosis (IAP) protein family that blocks cell death (55), and the transfer of these exosomes to breast cancer cells promotes cell survival in a Survivin-dependent manner (56). The gene discussed is BIRC5; the disease is breast carcinoma.